HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Harry P Kozakewich Selected Research
Harry P Kozakewich Research Topics
Disease
5
Hemangioma (Angioma)
03/2014 - 02/2003
4
Neoplasms (Cancer)
01/2018 - 12/2008
2
Vascular Malformations
03/2014 - 02/2005
1
Intractable Pain
03/2020
1
Pain (Aches)
03/2020
1
Secretory breast carcinoma
01/2018
1
Carcinoma (Carcinomatosis)
01/2018
1
Mesoblastic Nephroma (Congenital Mesoblastic Nephroma)
01/2018
1
Fibrosarcoma
01/2018
1
Hamartoma
01/2017
1
Sudden Infant Death (SID)
01/2017
1
Kaposiform Hemangioendothelioma
03/2014
1
Pyogenic Granuloma
03/2014
1
Arteriovenous Malformations (Arteriovenous Malformation)
03/2014
1
Enchondromatosis (Ollier Disease)
04/2011
1
Down Syndrome Critical Region
05/2009
1
Intestinal Volvulus (Volvulus)
02/2009
1
Lipoblastoma
02/2009
1
Hepatoblastoma
12/2008
1
Neuroblastoma
12/2008
1
Focal Nodular Hyperplasia
12/2008
1
Adamantinoma
03/2008
1
Cicatrix (Scar)
02/2005
1
Thrombosis (Thrombus)
02/2005
Drug/Important Bio-Agent (IBA)
1
RNA (Ribonucleic Acid)
IBA
01/2018
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2017
1
Biomarkers (Surrogate Marker)
IBA
01/2017
1
FSH Receptors (FSH Receptor)
IBA
03/2014
1
Follicle Stimulating Hormone (Follitropin)
FDA Link
03/2014
1
Fetal Proteins (Fetoprotein)
IBA
09/2011
1
DNA (Deoxyribonucleic Acid)
IBA
04/2011
1
Ephrins
IBA
05/2009
1
Jagged-1 Protein
IBA
05/2009
1
Insulin-Like Peptides
IBA
05/2009
1
Chemokines
IBA
05/2009
1
EphB3 Receptor
IBA
05/2009
1
plexin
IBA
05/2009
1
Neuropilin-2
IBA
05/2009
1
Angiopoietin-2
IBA
05/2009
1
Keratins (Keratin)
IBA
03/2008
1
Phenobarbital (Luminal)
FDA Link
02/2005
1
Coloring Agents (Dyes)
IBA
02/2003
Therapy/Procedure
3
Therapeutics
01/2018 - 01/2007
2
Surgical Amputation (Amputations)
03/2020 - 01/2017
1
Analgesia
03/2020
1
Lasers (Laser)
05/2009
1
Laparotomy
02/2009
1
Aftercare (After-Treatment)
12/2008
1
Segmental Mastectomy (Lumpectomy)
12/2008
1
Curettage
03/2008
1
Injections
02/2005
1
Sclerotherapy
02/2005